Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Clinical Research and Equipment Industry Analysis

UpdatedSep 16, 2026
DataAggregated Company Financials
Companies8
  • 7D0.7%
  • 3M3.2%
  • 1Y-17.0%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has dropped 3.2%, driven by a pullback from BICO Group of 3.3%. Overall the industry is down 17% in 12 months. Earnings are forecast to grow by 20% annually.

Industry Valuation and Performance

Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 16 Sep 2026SEK 22.6bSEK 12.6b-SEK 994,556,795.0032.5x-22.7x1.8x
Fri, 14 Aug 2026SEK 22.0bSEK 12.6b-SEK 1,069,777,579.0048.9x-20.6x1.8x
Sun, 12 Jul 2026SEK 29.6bSEK 14.6b-SEK 870,773,579.0034.2x-33.9x2x
Tue, 09 Jun 2026SEK 29.7bSEK 14.6b-SEK 871,304,353.0033.8x-34.1x2x
Thu, 07 May 2026SEK 28.2bSEK 14.6b-SEK 853,896,077.0032.7x-33.1x1.9x
Sat, 04 Apr 2026SEK 27.4bSEK 14.6b-SEK 971,664,077.0032.5x-28.1x1.9x
Mon, 02 Mar 2026SEK 29.1bSEK 14.6b-SEK 838,240,147.0033.6x-34.7x2x
Wed, 28 Jan 2026SEK 28.7bSEK 14.9b-SEK 744,515,427.0044.3x-38.5x1.9x
Fri, 26 Dec 2025SEK 31.5bSEK 14.9b-SEK 744,515,427.0050.2x-42.4x2.1x
Sun, 23 Nov 2025SEK 33.3bSEK 14.9b-SEK 744,515,427.0055.4x-44.7x2.2x
Tue, 21 Oct 2025SEK 34.6bSEK 14.7bSEK 61.3m55.1x564.4x2.4x
Thu, 18 Sep 2025SEK 36.2bSEK 14.7bSEK 61.3m60.3x591.1x2.5x
Sat, 16 Aug 2025SEK 34.9bSEK 14.8bSEK 161.3m58.6x216.2x2.4x
Mon, 14 Jul 2025SEK 47.2bSEK 16.6bSEK 416.3m67.9x113.4x2.8x
Wed, 11 Jun 2025SEK 47.0bSEK 16.6bSEK 404.2m71.1x116.3x2.8x
Fri, 09 May 2025SEK 46.1bSEK 16.6bSEK 422.0m44.4x109.3x2.8x
Sun, 06 Apr 2025SEK 34.6bSEK 16.6bSEK 609.4m36.8x56.8x2.1x
Tue, 04 Mar 2025SEK 40.3bSEK 16.6bSEK 615.4m40.9x65.5x2.4x
Thu, 30 Jan 2025SEK 39.8bSEK 16.7b-SEK 1,152,911,426.0043.1x-34.5x2.4x
Sat, 28 Dec 2024SEK 44.2bSEK 16.7b-SEK 1,152,911,426.0050.9x-38.3x2.6x
Mon, 25 Nov 2024SEK 42.5bSEK 16.8b-SEK 948,723,426.0048.3x-44.8x2.5x
Wed, 23 Oct 2024SEK 47.5bSEK 16.7b-SEK 988,175,491.0078.9x-48.1x2.9x
Fri, 20 Sep 2024SEK 47.1bSEK 16.7b-SEK 988,175,491.0058.1x-47.6x2.8x
Sun, 18 Aug 2024SEK 48.2bSEK 16.7b-SEK 1,124,972,538.0061.5x-42.9x2.9x
Tue, 16 Jul 2024SEK 47.0bSEK 16.3b-SEK 1,188,686,510.0058x-39.5x2.9x
Thu, 13 Jun 2024SEK 43.1bSEK 16.3b-SEK 1,188,686,510.0058.4x-36.2x2.6x
Sat, 11 May 2024SEK 40.3bSEK 16.3b-SEK 1,157,635,671.0036.5x-34.8x2.5x
Mon, 08 Apr 2024SEK 39.3bSEK 16.0b-SEK 1,122,792,213.0037.3x-35x2.5x
Wed, 06 Mar 2024SEK 37.5bSEK 16.0b-SEK 1,123,139,210.0039.4x-33.4x2.3x
Fri, 02 Feb 2024SEK 39.3bSEK 15.6b-SEK 1,371,823,683.0046.7x-28.7x2.5x
Sun, 31 Dec 2023SEK 37.7bSEK 15.5b-SEK 1,393,723,683.0045.7x-27x2.4x
Tue, 28 Nov 2023SEK 33.8bSEK 15.4b-SEK 1,395,872,683.0039.1x-24.2x2.2x
Thu, 26 Oct 2023SEK 25.2bSEK 15.1b-SEK 1,134,516,711.0032.5x-22.2x1.7x
Sat, 23 Sep 2023SEK 27.5bSEK 15.1b-SEK 1,133,713,072.0038.8x-24.3x1.8x
Price to Earnings Ratio

-24.3x


Total Market Cap: SEK 27.5bTotal Earnings: -SEK 1,133,713,072.00Total Revenue: SEK 15.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Clinical Research and Equipment Industry Price to Earnings3Y Average 28.9x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 2.3x is higher than the industry's current PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 5.8% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Comparison

How does Swedish Clinical Research and Equipment compare with similar industries?

SE Market-2.77%
Healthcare-1.69%
Life Sciences0.68%
Clinical Research and Equipment0.68%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ALIF B AddLifeSEK 159.601.1%
+SEK 207.2m		-17.7%PE32.5x
PRO PromimicSEK 10.1020.2%
+SEK 32.1m		-39.7%PS4.2x
LEVBIO Level BioSEK 0.276.3%
+SEK 1.1m		-16.8%PE3.9x

Latest News

ALIF B
SEK 159.60
AddLife
7D
1.1%
1Y
-17.7%
BICO
SEK 20.45
BICO Group
7D
-3.3%
1Y
-1.9%
Narrative Update • Sep 09

BICO: Leadership Transition And Margin Focus Will Support Future Upside

Analysts have lifted their price target on BICO Group to SEK39 from SEK31 as they incorporate a lower discount rate, slightly revised revenue and margin forecasts, and a higher assumed future P/E multiple in their updated valuation work. What’s in the News for BICO Group BICO Group plans a CEO transition with Anders Fogelberg appointed as CEO, effective 1 September 2026.
LEVBIO
SEK 0.27
Level Bio
7D
6.3%
1Y
-16.8%
IDLDX
SEK 0.38
IDL Diagnostics
7D
-7.1%
1Y
-5.2%
PRO
SEK 10.10
Promimic
7D
20.2%
1Y
-39.7%
PEXA B
SEK 0.23
PExA
7D
-1.7%
1Y
-40.4%
MAGLE
SEK 0.38
Magle Chemoswed Holding
7D
-4.5%
1Y
-98.2%
GENO
SEK 20.30
Genovis AB (publ.)
7D
-2.2%
1Y
-15.6%
Analysis Article • Jul 31

Some May Be Optimistic About Genovis AB (publ.)'s (STO:GENO) Earnings

The market for Genovis AB (publ.)'s ( STO:GENO ) shares didn't move much after it posted weak earnings recently. We...